Proxima Therapeutics Release: First Data On GliaSite Radiation Therapy System As Primary Treatment For Metastatic Brain Cancer Presented At Radiation Oncology Meeting
10/19/2005 5:11:45 PM
Proxima Therapeutics, Inc. today announced encouraging results of a post-market study on the GliaSite Radiation Therapy System as a first-line treatment for single resected brain metastasis. Each year, more than 150,000 people are diagnosed with metastatic brain tumors--tumors that first exist in other parts of the body and then spread to the brain. Details from this multi-center study were presented at the Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) taking place in Atlanta, October 3-7, in a poster discussion entitled, "Interim Results of a Phase II Study of Resection and GliaSite Brachytherapy for a Single Brain Metastasis," presented by Dr. Lisa Rogers of Henry Ford Hospital in Detroit.
comments powered by